| | | | | |
CTKB Cytek Biosciences, Inc. Common Stock | $4,4300 | -0,23% | $621,31M | $142,00 | |
FDMT 4D Molecular Therapeutics, Inc. Common Stock | $15,3700 | -0,13% | $620,51M | $4,49K | |
EIKN Eikon Therapeutics, Inc. Common Stock | $11,1800 | +0,18% | $619,88M | $351,61K | |
| $19,2100 | +0,58% | $619,48M | $104,00 | |
| $59,2750 | -0,11% | $618,62M | $13,00 | |
EMD Western Asset Emerging Markets Debt Fund, Inc | $10,5000 | +0,00% | $618,50M | $133,69K | |
CBNK Capital Bancorp, Inc. | $36,5400 | -0,05% | $617,08M | $5,000 | |
NRDS NerdWallet, Inc. Class A Common Stock | $10,1400 | +0,00% | $616,85M | $18,00 | |
| $74,2950 | -0,07% | $616,57M | $848,00 | |
TRAX First Tracks Biotherapeutics, Inc. Ordinary Shares | $43,2700 | -0,02% | $615,50M | $4,000 | |
CGNT Cognyte Software Ltd. Ordinary Shares | $8,5400 | +0,00% | $613,97M | $329,00 | |
BWB Bridgewater Bancshares, Inc. Common Stock | $21,6900 | +0,05% | $613,72M | $127,22K | |
VINP Vinci Compass Investments Ltd. Class A Common Shares | $9,6400 | -0,21% | $613,18M | $30,00 | |
ELMT The Elmet Group Co. Common Stock | $17,6950 | +0,20% | $612,93M | $2,37K | |
| $7,2000 | +1,70% | $611,79M | $650,00 | |
